Find News

Filter articles

Showing 11 to 20 of 4009 results

UPC judge and Regeneron counsel urge lobbying to improve court's transparency

EU, UK23-11-2023Legal developmentsMarisa Woutersen

Judge encourages lawyers and public to make their voices heard over transparency concerns | Awkward access to public hearings ‘causing problems’ says Regeneron counsel | Plea for public virtual hearings as judge notes that requests have been ‘coming in by the dozen’ | Panellists discuss at LSPN Europe.

EPO revokes Moderna's COVID-19 vaccine patent

EU23-11-2023Legal developmentsLiz Hockley

The European Patent Office hands a win to BioNTech and Pfizer in coronavirus vaccine dispute | US biotech plans to appeal decision affecting mRNA patent.

10x Genomics awarded $31m in key ruling over NanoString

21-11-2023Marisa Woutersen

District court’s verdict found NanoString infringed on seven patents related to protein detection tech | Marks the third victory for 10x Genomics in the last six months | NanoString ‘must drop the charade’ says 10x CEO.

AbbVie accused of delay tactics in $1.3bn Humira dispute

Netherlands16-11-2023Legal developmentsMuireann Bolger

Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time.

Cancer specialist to pay $83.4m over DNA sequencing infringement

US16-11-2023Marisa Woutersen

TwinStrand Biosciences and the University of Washington win patent infringement case related to DNA mutation technology.

Saxton & Stump adds senior tech counsel

US16-11-2023Marisa Woutersen

New senior counsel joins IP group from previous roles at a Pittsburgh university, robotics company, and founding own law firm | Experience in patent prosecution in tech for life science sectors.

Neurocrine resolves dispute over Huntington's treatment

US14-11-2023Marisa Woutersen

Neuroscience-focused biopharma ends litigation with four companies | Companies can introduce generic alternatives in the future.

USPTO aims to fend off Fintiv challenge at SCOTUS

US14-11-2023Muireann Bolger

Controversial rule precludes a patent review if there is parallel litigation | Big pharma and tech companies insist the rule is “arbitrary and capricious” | US agency backs Vidal’s authority, calling a proposed intervention “unnecessary”.

Taiwan company fails to overturn PTAB decision over eye treatment patent

US09-11-2023Marisa Woutersen

Federal Circuit rejects appeal in patent dispute with California’s Cloudbreak Theraputics | Court stated failure to prove concrete injury.

FTC challenges more than 100 pharma patents

US09-11-2023Muireann Bolger

Commission targets big pharma companies over ‘improper listings’ | Agency argues that alleged inaccuracies may delay lower-cost generic drug competition, stall drug development, and stifle innovation.

Showing 11 to 20 of 4009 results